Sorry, you need to enable JavaScript to visit this website.

Patient Support & Access | XARELTO® (rivaroxaban) HCP
  1. Access and Support
  2. Access and Support

COMPREHENSIVE ACCESS AND SUPPORT

Covered at the preferred brand tier for more* patients than any other DOAC1

Once a decision has been made to prescribe XARELTO®...

Janssen now offers two key programs for XARELTO®

Janssen CarePath gives you access, affordability and treatment support for your patients

Comprehensive information on health plan coverage

Affordability Helping Patients Afford XARELTO®

Coverage Gap Support

Janssen Care Path provides HCPs with information and support to help your patients start and stay on their prescribed Janssen medications. We provide information on payer coverage processes, the exceptions and appeals process, and reimbursement.

Prior Authorization (PA) Support for XARELTO®

CoverMyMeds® is a third-party service provider whose standard process allows for the secure electronic communication of prior authorization requests, inquiries, or notifications between providers, payers, and pharmacies through their online portal.

Janssen has entered into a contract with CoverMyMeds to allow pharmacies to initiate PA requests to providers upon Rx rejection, and alert the provider that the medication requires a PA. Providers can access this functionality on CoverMyMeds.com.

If you have any questions or need support, call 888-XARELTO (888-927-3586), Monday-Friday, 8:00 AM-8:00 PM ET.

Visit JanssenCarePath.com.

Create a Provider Portal account at JanssenCarePathPortal.com to enroll patients in the Savings Program, view their Savings Program benefits, and other resources.

XARELTO withMe Coverage Gap Support

Are your patients worried about cost? XARELTO withMe is here to help.

If your patients fall into a coverage gap, such as the Medicare Part D coverage gap or commercial high deductibles, they could enroll in XARELTO withMe Coverage Gap Support and pay $89 monthly for a 30-day supply or $250 for a 90-day supply, plus sales tax if applicable, for XARELTO®, if they qualify.

Program starts April 1st and ends December 31st.

Why XARELTO withMe Coverage Gap Support?

  • Helps eligible patients lower XARELTO® costs during a coverage gap
  • Alerts patients when they enter a coverage gap
  • Delivers the patient's medication conveniently to their door
  • Requires no fees or income information
  • Automatically refills XARELTO® prescriptions that you authorize

To register, patients must have insurance covering a portion of the cost of XARELTO® and are being asked to pay more than $89 monthly for XARELTO® through their insurance.

Terms expire at the end of each calendar year and may change. See Coverage Gap Support Program Requirements.

Only patients can sign up at XARELTOwithMe.com or by calling 888-XARELTO (888-927-3586), Monday-Friday, 8:00 AM-8:00 PM ET.

Visit JanssenCarePath.com.

XARELTO withMe: For Patients

XARELTO withMe supports your patients throughout their treatment journey.

With personalized support, XARELTO withMe may help your patients save on out-of-pocket costs for XARELTO®. And if they become eligible for cost support along the way, we'll stay in touch and let them know. Plus, we'll provide a variety of educational resources to help patients better understand their condition and treatment.

XARELTO withMe is designed to help eligible patients:

  • Learn about options that may lower out-of-pocket prescription costs, including information about:
    • XARELTO withMe Savings Card for commercially insured patients
    • XARELTO withMe Coverage Gap Support for patients who fall into a coverage gap, such as the Medicare Part D coverage gap or commercial high deductibles
  • Get educational materials and tools to support them along their treatment journey
  • Keep their treatment routine on track with refill notifications

Only patients can sign up at XARELTOwithMe.com or by calling 888-XARELTO (888-927-3586), Monday-Friday, 8:00 AM-8:00 PM ET.

FORMULARY COVERAGE WITH XARELTO®

Janssen is dedicated to making XARELTO® affordable and accessible for all patients. XARELTO® is widely accessible nationwide with preferred coverage for ~95% of commercial and >95% of Medicare Part D patients.1

To see the formulary coverage for your patients, enter your ZIP code. Your results will appear below.

Collected in 11/23 and may change.

This percentage may not represent 100% of formulary lives due to data limitations.

This information is not a promise of coverage or payment. It is not intended to give reimbursement advice or increase reimbursement by any payer. Legal requirements and plan information can be updated frequently. Contact the plan for more information about current coverage, reimbursement policies, restrictions, or requirements that may apply.

Please see below for details regarding references and footnotes.

SUPPORT FOR PATIENTS UNDERINSURED OR PATIENTS WITHOUT INSURANCE COVERAGE

ADDITIONAL AFFORDABILITY SUPPORT FROM JANSSEN

Patient assistance is available if your patient has commercial, employer-sponsored, or government coverage that does not fully meet their needs. Your patient may be eligible to receive their Janssen medication free of charge for up to one year if they meet the eligibility and income requirements for the Janssen Patient Assistance Program. See terms and conditions at PatientAssistanceInfo.com or call 833-742-0791.

Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF)

The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is an independent, nonprofit organization. JJPAF gives eligible patients free prescription medicines donated by Johnson & Johnson companies. Patients may be eligible if they don't have insurance.

Do you have patients who may need help? They can see if they are eligible and get an application at www.JJPAF.org or call 800-652-6227 [Monday through Friday, 8:00 AM to 8:00 PM ET].

The patient support and resources provided by XARELTO withMe are not intended to provide medical advice, replace a treatment plan from the patient's doctor or nurse, provide case management services or serve as a reason to prescribe XARELTO®.

*“More” refers to an absolute difference greater than or equal to ±5%.

†Within 2% of the access being stated.

Reference: 1: Source: Managed Markets Insight and Technology, LLC™, a trademark of MMIT, as of April 03, 2023.